MAPT and Parkinson disease: Consistent with pS106-Rab12 labeling of tau pathology, pS106-Rab12-positive area was significantly elevated in LRRK2GS PD (Braak > 3) compared to both control and LRRK2GS PD (Braak ≤ 3) cases (Fig. 8b).